| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GDC-0941 | GDSC1000 | pan-cancer | AAC | -0.038 | 0.2 |
| mRNA | crizotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.04 | 0.2 |
| mRNA | BRD-K09587429 | CTRPv2 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | BRD8899 | CTRPv2 | pan-cancer | AAC | 0.044 | 0.2 |
| mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | 0.039 | 0.2 |
| mRNA | VU0155056 | CTRPv2 | pan-cancer | AAC | 0.043 | 0.2 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | -0.04 | 0.3 |
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | 0.041 | 0.3 |
| mRNA | CD-1530 | CTRPv2 | pan-cancer | AAC | 0.043 | 0.3 |
| mRNA | ML312 | CTRPv2 | pan-cancer | AAC | -0.082 | 0.3 |